New data for Roche’s Ocrevus show benefit in disability progression and cognitive decline in secondary progressive and primary progressive multiple sclerosis Read more
UP’s Diploma Pharmacist Gazetted Officer Association appoints Alok Pandey as new district President Read more
EMA increases general, non-pharmacovigilance fees by 0.3 per cent and 5.3 per cent from 1st April, 2022 Read more
US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults Read more